Cardiovascular Systems, Inc. to Release Late-Breaking Coronary Data at C3 Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present data from its ORBIT II study of coronary artery disease in a late-breaking presentation at the 2013 Complex Cardiovascular Catheter Therapeutics (C3) conference in Orlando, Fla.
Dr. Jeffrey Chambers, Metropolitan Heart and Vascular Institute, Minneapolis, will present “Treatment and Procedural Outcomes of the ORBIT II Trial Treating De Novo Severely Calcified Coronary Lesions” on Thursday, June 20, from 2:10 to 2:25 p.m.
Help employers find you! Check out all the jobs and post your resume.
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present data from its ORBIT II study of coronary artery disease in a late-breaking presentation at the 2013 Complex Cardiovascular Catheter Therapeutics (C3) conference in Orlando, Fla.
Dr. Jeffrey Chambers, Metropolitan Heart and Vascular Institute, Minneapolis, will present “Treatment and Procedural Outcomes of the ORBIT II Trial Treating De Novo Severely Calcified Coronary Lesions” on Thursday, June 20, from 2:10 to 2:25 p.m.
Help employers find you! Check out all the jobs and post your resume.